Numerous studies have demonstrated that the consumption of various biologically active compounds, adjacent to insulin treatment, have the ability to effectively regulate postprandial glycemia and can be used as alternatives to drugs for the development and control of diabetes [33]. This evidence concerns the gene INS and diabetes mellitus.